Request Demo
Last update 08 May 2025
Cytomegalovirus Immune Globulin(pH4)(Chengdu Rongsheng Pharmaceutical Co., Ltd.)
Last update 08 May 2025
Overview
Basic Info
Drug Type Immunoglobulin |
Synonyms- |
Target- |
Action modulators |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Cytomegalovirus Immune Globulin(pH4)(Chengdu Rongsheng Pharmaceutical Co., Ltd.)CTR20210906
一项随机、开放、平行对照、多中心的评价静注巨细胞病毒人免疫球蛋白（pH4）联合抗病毒药物抢先治疗异基因造血干细胞移植后巨细胞病毒感染的有效性和安全性的 III 期临床研究
[Translation] A randomized, open, parallel-controlled, multicenter phase III clinical study to evaluate the efficacy and safety of intravenous cytomegalovirus human immunoglobulin (pH4) combined with antiviral drugs in the preemptive treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
CTR20180496
CMV静丙治疗异基因造血干细胞移植后CMV感染的有效性和安全性的随机、开放、阳性对照、多中心临床研究
[Translation] A randomized, open, positive-controlled, multicenter clinical study on the efficacy and safety of intravenous CMV in the treatment of CMV infection after allogeneic hematopoietic stem cell transplantation
100 Clinical Results associated with Cytomegalovirus Immune Globulin(pH4)(Chengdu Rongsheng Pharmaceutical Co., Ltd.)
Login to view more data
100 Translational Medicine associated with Cytomegalovirus Immune Globulin(pH4)(Chengdu Rongsheng Pharmaceutical Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with Cytomegalovirus Immune Globulin(pH4)(Chengdu Rongsheng Pharmaceutical Co., Ltd.)
Login to view more data
100 Deals associated with Cytomegalovirus Immune Globulin(pH4)(Chengdu Rongsheng Pharmaceutical Co., Ltd.)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cytomegalovirus Infections | Phase 3 | China | 08 Jun 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free